8. Huntington disease
197 clinical trials,   171 drugs   (DrugBank: 54 drugs),   82 drug target genes,   144 drug target pathways

Searched query = "Huntington disease", "Huntington chorea"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01897896
(ClinicalTrials.gov)
November 12, 201314/6/2013Alternatives for Reducing Chorea in Huntington DiseaseAn Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington DiseaseChorea Associated With Huntington DiseaseDrug: SD-809Auspex Pharmaceuticals, Inc.NULLCompleted18 YearsN/AAll119Phase 3United States;Australia;Canada
2NCT01795859
(ClinicalTrials.gov)
August 5, 201320/2/2013First Time Use of SD-809 in Huntington DiseaseA Randomized Double-Blind, Placebo-Controlled Study of SD-809 Extended Release for the Treatment of Chorea Associated With Huntington DiseaseChoreaDrug: SD-809;Drug: PlaceboTeva Pharmaceutical IndustriesNULLCompleted18 YearsN/AAll90Phase 3United States;Australia;Canada